» Articles » PMID: 20802930

Seroprevalence of Cytomegalovirus Antibodies in Blood Donors in Southern, Brazil

Overview
Specialty Tropical Medicine
Date 2010 Aug 31
PMID 20802930
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cytomegalovirus (CMV) infection is a matter of concern for blood bank professionals and blood transfusion recipients, especially in cases of transfusions to neonates and immunocompromised patients. Thus, the present study aimed to determine the seroprevalence of CMV IgG and IgM antibodies among blood donors in the city of Lages, in the mountain region of Santa Catarina, southern Brazil, and to investigate possible associations between the socioeconomic characteristics of donors and CMV serological status.

Methods: A seroepidemiological cross-sectional study was conducted on 1,045 blood samples from donors that were used in serological screening over a one-year investigation. All the analyses were conducted using the microparticle enzyme immunoassay with Biokit(R) reagents (Barcelona, Spain), in accordance with the manufacturer's instructions.

Results: Anti-CMV IgG seroprevalence in the sample studied was 96.4% (95% CI: 95.23 - 97.50) and that of anti-CMV IgM was 2.3% (95% CI: 1.39 - 3.20). There were no statistically significant associations between the presence of antibodies and the socioeconomic characteristics of donors.

Conclusions: The blood donors in the study region had high seroprevalence of anti-CMV IgG. Thus, blood component screening strategies and careful indication for blood transfusions require special attention among healthcare professionals as part of the actions for prevention and reduction of primary infections caused by CMV.

Citing Articles

Prevalence and investigation of Cytomegalovirus (HCMV) in blood donors from the main blood establishment in Rio de Janeiro/Brazil.

Oliveira A, Pereira J, Nunes G, Sousa Junior I, Sarmento D, Lopes J Braz J Infect Dis. 2025; 29(2):104508.

PMID: 39922051 PMC: 11848753. DOI: 10.1016/j.bjid.2025.104508.


Human cytomegalovirus (HCMV) trends in Sri Lanka: insights from a hospital-based seroprevalence analysis.

Sunil-Chandra N, Jayasundara M, Gunathilaka M, Suminda S BMC Infect Dis. 2025; 25(1):184.

PMID: 39920600 PMC: 11806834. DOI: 10.1186/s12879-025-10594-2.


Ganciclovir Resistance-Linked Mutations in the HCMV Gene: Sanger Sequencing Analysis in Samples from Transplant Recipients at a Tertiary Hospital in Southern Brazil.

da Rocha A, Rodrigues G, da Silva Hellwig A, Pereira D, Volpato F, Barth A Diagnostics (Basel). 2025; 15(2).

PMID: 39857098 PMC: 11765014. DOI: 10.3390/diagnostics15020214.


Cytomegalovirus in Adenoma and Carcinoma Lesions: Detecting Mono-Infection and Co-Infection in Salivary Glands.

Guimaraes A, Raposo Vedovi J, de Almeida Ribeiro C, Martinelli K, Machado M, de Abreu Manso P Int J Mol Sci. 2024; 25(14).

PMID: 39062747 PMC: 11276870. DOI: 10.3390/ijms25147502.


Analysis of Serum Immunoglobulin G (IgG) Levels against , Herpes Simplex Virus Types 1 and 2, Cytomegalovirus and Hepatitis C Virus in Vitiligo.

Ribeiro R, Lacerda K, Guillo L Indian J Dermatol. 2023; 68(5):588.

PMID: 38099098 PMC: 10718258. DOI: 10.4103/ijd.ijd_950_22.